Data search
Results for MligTC455_46566
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} |
Cumulative graph for MligTC455_46566
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.522 | 2.065 | 0.75512 | 1.00000 | |
| RegionR2 | 2.352 | 2.065 | 0.00040 | 0.01128 | |
| RegionR3 | -1.617 | 2.065 | 0.03123 | 0.30474 | |
| RegionR4 | -1.447 | 2.065 | 0.06443 | 0.22866 | |
| RegionR5 | -1.28 | 2.065 | 0.05029 | 0.18827 | |
| RegionR6 | -1.874 | 2.065 | 0.02576 | 0.29348 | |
| RegionR7 | 0.969 | 2.065 | 0.22020 | 0.84071 | |
| RegionR8 | 2.375 | 2.065 | 0.00226 | 0.08091 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -5.46 | 2.065 | 0.31598 | 1.00000 | |
| RegenerationR2 | -0.864 | 2.065 | 0.10579 | 0.51141 | |
| RegenerationR3 | -0.23 | 2.065 | 0.79349 | 0.98003 | |
| RegenerationR4 | 0.298 | 2.065 | 0.71998 | 0.96148 | |
| RegenerationR5 | -1.482 | 2.065 | 0.09139 | 0.46459 | |
| RegenerationR6 | 0.056 | 2.065 | 0.96746 | 1.00000 | |
| RegenerationBL | -1.984 | 2.065 | 0.11876 | 0.40800 | |
| RegenerationTP | -1.242 | 2.065 | 0.15737 | 0.58510 |
Genes with expression patterns similar to MligTC455_46566
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
| 2. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 3.701 | 0.978 | - | 0.900 | 0.919 | 0.904 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
| 3. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 3.687 | 0.966 | - | 0.926 | 0.884 | 0.911 | - | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
| 4. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
3.68 | 0.862 | - | 0.922 | 0.933 | 0.963 | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
| 5. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
3.655 | 0.988 | - | 0.871 | 0.927 | 0.869 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
| 6. | MligTC455_22428 | 96 | 2.01 | Mlig455_011005 | Neo: - Age: - |
3.592 | - | - | 0.879 | 0.911 | 0.956 | 0.846 | Mlig455_011005 {REF} {Length: 3873} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=22.2]; Telomere-associated protein TERB2 [PF15101.8, score=20.0]; ZIP Zinc transporter [PF02535.24, score=18.7]; Ureide permease [PF07168.13, score=17.4]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=151, Expect=2e-37]} {RNA1310_98904} | |
| 7. | MligTC455_29168 | 95 | 1.99 | Mlig455_001005 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.838/0.04040 |
DNAH5 | 3.547 | 0.993 | - | 0.794 | - | 0.905 | 0.855 | Mlig455_001005 {REF} {Length: 14882} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=578.4]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=431.3]; Dynein heavy chain C-terminal domain [PF18199.3, score=314.7]; P-loop containing dynein motor region D4 [PF12780.9, score=302.4]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.7]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.1]; Microtubule-binding stalk of dynein motor [PF12777.9, score=143.2]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.5]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.7]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=22.0]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.4]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6260, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6234, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5093, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1290, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6941, Expect=0.0]} {RNA1509_51275} {RNA1310_408, RNA1509_51275} {RNA1509_51275, RNA815_44.1} |
| 8. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 3.529 | 0.980 | - | 0.914 | 0.826 | 0.809 | - | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
| 9. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 3.527 | 0.979 | - | 0.805 | 0.822 | 0.921 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
| 10. | MligTC455_48230 | 218 | 4.55 | Mlig455_025904 | Neo: - Age: - |
3.481 | 0.964 | - | 0.915 | 0.794 | - | 0.808 | Mlig455_025904 {REF} {Length: 3803} {Pfam: Domain of unknown function (DUF4139) [PF13598.8, score=147.7]; N-terminal domain of unknown function (DUF4140) [PF13600.8, score=63.8]} {Celegans: WBGene00016877, C52D10.3, [Score=253, Expect=5e-74]} {Smed: dd_Smed_v6_3629_0_1, dd_Smed_v6_3629_0_1, [RH, Score=449, Expect=7e-148]} {RNA1509_25634} {RNA1310_6356.1} {RNA815_11616} | |
| 11. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
3.471 | 0.974 | - | 0.923 | - | 0.715 | 0.859 | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
| 12. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
3.47 | - | - | 0.931 | 0.952 | 0.803 | 0.784 | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
| 13. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
3.463 | - | - | 0.860 | 0.910 | 0.954 | 0.739 | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
| 14. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
3.46 | - | - | 0.786 | 0.840 | 0.968 | 0.866 | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
| 15. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
3.447 | 0.880 | - | 0.858 | 0.754 | 0.955 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
| 16. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
3.436 | - | - | 0.740 | 0.853 | 0.983 | 0.860 | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
| 17. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 3.423 | - | - | 0.790 | 0.864 | 0.969 | 0.800 | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
| 18. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
3.418 | 0.959 | - | 0.777 | 0.907 | 0.775 | - | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
| 19. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
3.391 | 0.862 | - | 0.727 | 0.847 | 0.955 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
| 20. | MligTC455_53707 | 903 | 18.82 | Mlig455_001231 | Neo: - Age: Down-Up-Up Region-specific R2: 3.242 Region-enriched R2: 1.917/0.00133 Regeneration-downregulated BL: -2.295 Regeneration-depleted BL: -2.295 |
3.384 | - | - | 0.820 | 0.963 | 0.859 | 0.742 | Mlig455_001231 {REF} {Length: 737} {RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1310_60643.1, RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1509_13584, RNA1509_53181, RNA1509_55651, RNA815_32307.1} | |
| 21. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 3.347 | - | - | 0.816 | 0.818 | 0.958 | 0.755 | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
| 22. | MligTC455_33511 | 496 | 10.33 | Mlig455_019112 | Neo: - Age: - Region-enriched R2: 2.637/0.00674 |
INPP1 | 3.319 | 0.958 | - | 0.791 | 0.783 | 0.787 | - | Mlig455_019112 {REF} {Length: 2860} {Pfam: Inositol monophosphatase family [PF00459.27, score=118.2]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=262, Expect=4e-83]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [RH, Score=297, Expect=7e-97]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [RH, Score=252, Expect=6e-80]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=74.7, Expect=1e-14]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [RH, Score=197, Expect=6e-59]} {RNA1509_8591} {RNA1310_6898.1} {RNA815_7520} |
| 23. | MligTC455_49863 | 62 | 1.29 | Mlig455_019320, Mlig455_019542 | Neo: - Age: - |
SHOX2 | 3.3 | - | - | 0.786 | 0.835 | 0.968 | 0.711 | Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} |
| 24. | MligTC455_35044 | 248 | 5.17 | Mlig455_037400 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.538/0.00372 |
3.225 | - | - | 0.785 | 0.743 | 0.951 | 0.746 | Mlig455_037400 {REF} {Length: 2022} {RNA1509_41763} {RNA1310_23070.1, RNA1509_41763} {RNA1509_41763, RNA815_9632} | |
| 25. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 2.891 | 0.985 | - | - | 0.936 | 0.970 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
| 26. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 2.87 | - | - | 0.974 | 0.928 | 0.968 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
| 27. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.866 | - | - | 0.953 | 0.935 | 0.978 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 28. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
2.857 | - | - | 0.961 | 0.933 | 0.963 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
| 29. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.849 | - | - | 0.950 | 0.928 | 0.971 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
| 30. | MligTC455_35813 | 35 | 0.73 | Mlig455_013562, Mlig455_013615 | Neo: - Age: - Region-enriched R2: 7.733/0.00085 |
NPR2 | 2.846 | - | - | 0.918 | 0.971 | 0.957 | - | Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869} Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407} |
| 31. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 2.843 | - | - | 0.936 | 0.936 | 0.971 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
| 32. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.834 | - | - | 0.937 | 0.933 | 0.964 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
| 33. | MligTC455_39463 | 228 | 4.76 | Mlig455_025914, Mlig455_025946 | Neo: - Age: - Regeneration-downregulated R4: -3.846 Regeneration-depleted R4: -3.846 |
2.831 | - | - | - | 0.923 | 0.951 | 0.957 | Mlig455_025914 {REF} {Length: 1257} {RNA1310_37139.1} {RNA815_50944} Mlig455_025946 {REF} {Length: 2808} {tRNA: Ala(CGC),pseudo, score=22.1} {Pfam: Lectin C-type domain [PF00059.23, score=35.2]} {Smed: dd_Smed_v6_84586_0_1, dd_Smed_v6_84586_0_1, [RH, Score=53.1, Expect=4e-09]} {RNA1509_4810} {RNA1310_37139.1} {RNA815_40603} |
|
| 34. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.825 | - | - | 0.918 | 0.937 | 0.970 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
| 35. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.823 | - | - | 0.920 | 0.937 | 0.966 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
| 36. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.823 | - | - | 0.928 | 0.922 | 0.973 | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
| 37. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
2.822 | - | - | 0.942 | 0.905 | 0.975 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
| 38. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
2.821 | - | - | 0.921 | 0.921 | 0.979 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
| 39. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
2.814 | - | - | 0.911 | 0.935 | 0.968 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
| 40. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.811 | - | - | 0.913 | 0.924 | 0.974 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 41. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
2.811 | - | - | 0.901 | 0.933 | 0.977 | - | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
| 42. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 2.808 | - | - | 0.908 | 0.939 | 0.961 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
| 43. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
2.807 | - | - | 0.966 | 0.896 | 0.945 | - | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
| 44. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 2.804 | - | - | 0.927 | 0.902 | 0.975 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
| 45. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 2.799 | - | - | 0.963 | 0.871 | 0.965 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
| 46. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 2.796 | - | - | 0.975 | 0.874 | 0.947 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
| 47. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
2.793 | - | - | 0.913 | 0.916 | 0.964 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
| 48. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
2.789 | - | - | 0.917 | 0.916 | 0.956 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
| 49. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.783 | - | - | 0.893 | 0.921 | 0.969 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
| 50. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 2.779 | - | - | 0.941 | 0.867 | 0.971 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
| 51. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 2.767 | - | - | 0.911 | 0.872 | 0.984 | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
| 52. | MligTC455_14845 | 166 | 3.46 | Mlig455_011437 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.201/0.00360 |
2.763 | 0.966 | - | - | 0.904 | 0.893 | - | Mlig455_011437 {REF} {Length: 1014} {RNA1509_51062} {RNA1310_44466} {RNA815_28616} | |
| 53. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
2.763 | - | - | 0.913 | 0.887 | 0.963 | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 54. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
2.756 | - | - | 0.860 | 0.943 | 0.953 | - | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
| 55. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 2.753 | - | - | 0.952 | 0.855 | 0.946 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
| 56. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.751 | - | - | 0.920 | 0.881 | 0.950 | - | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
| 57. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
2.75 | - | - | 0.843 | 0.936 | 0.971 | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
| 58. | MligTC455_19567 | 76 | 1.59 | Mlig455_017855, Mlig455_047877 | Neo: - Age: - Region-enriched R2: 7.793/0.00005 |
2.748 | - | - | 0.962 | 0.893 | 0.893 | - | Mlig455_017855 {REF} {Length: 1874} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.0]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=3e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} Mlig455_047877 {REF} {Length: 1820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.8]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=2e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} |
|
| 59. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
2.747 | - | - | 0.844 | 0.939 | 0.964 | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
| 60. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
2.746 | 0.931 | - | - | 0.852 | 0.963 | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
| 61. | MligTC455_33939 | 15 | 0.31 | Mlig455_018477 | Neo: Int S/G2/M |
GUCY1B1 | 2.744 | - | - | 0.828 | 0.938 | 0.978 | - | Mlig455_018477 {REF} {Length: 4178} {Pfam: Heme NO binding associated [PF07701.16, score=239.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=198.0]; Haem-NO-binding [PF07700.17, score=172.7]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=343, Expect=9e-106]} {Mouse: ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=350, Expect=4e-106]; ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=348, Expect=7e-108]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=622, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=530, Expect=2e-176]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=818, Expect=0.0]} {RNA1509_41885} {RNA1310_21359} {RNA815_6599.2} |
| 62. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 2.741 | - | - | 0.887 | 0.898 | 0.956 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
| 63. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
2.739 | 0.956 | - | 0.882 | 0.901 | - | - | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
| 64. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 2.737 | 0.981 | - | 0.818 | 0.938 | - | - | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
| 65. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 2.734 | - | - | 0.906 | - | 0.953 | 0.875 | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
| 66. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
2.732 | - | - | 0.952 | 0.938 | 0.842 | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
| 67. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 2.729 | - | - | 0.917 | 0.852 | 0.960 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
| 68. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
2.726 | - | - | 0.854 | 0.958 | 0.914 | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
| 69. | MligTC455_51288 | 32 | 0.66 | Mlig455_033307 | Neo: - Age: - |
NRG2 | 2.726 | - | - | 0.830 | 0.906 | 0.990 | - | Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218} |
| 70. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
2.725 | - | - | 0.822 | 0.930 | 0.973 | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
| 71. | MligTC455_50455 | 972 | 20.25 | Mlig455_070346 | Neo: - Age: - Region-specific R2: 4.855 Region-enriched R2: 5.186/0.00000 |
2.723 | - | - | 0.863 | 0.899 | 0.961 | - | Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071} | |
| 72. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
2.719 | - | - | 0.825 | 0.935 | 0.959 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
| 73. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
2.718 | - | - | 0.902 | 0.839 | 0.977 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
| 74. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
2.711 | - | - | 0.814 | 0.935 | 0.962 | - | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
| 75. | MligTC455_16846 | 158 | 3.3 | Mlig455_051873 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.265/0.00110 |
PRSS33 | 2.71 | - | - | 0.951 | 0.867 | 0.892 | - | Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840} |
| 76. | MligTC455_27826 | 3365 | 70.11 | Mlig455_012369 | Neo: - Age: logFC(26M/2M)=-0.363 Region-specific R2: 3.166 Region-enriched R8: 2.483/0.00000 Regeneration-depleted BL: -1.955 |
2.705 | - | - | 0.857 | 0.953 | 0.895 | - | Mlig455_012369 {REF} {Length: 1066} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=18.4]} {RNA1509_28537, RNA1509_7615} {RNA1310_59305, RNA1509_28537, RNA1509_7615} {RNA1509_28537, RNA1509_7615, RNA815_42608} | |
| 77. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.701 | - | - | 0.810 | 0.931 | 0.960 | - | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
| 78. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 2.698 | - | - | 0.952 | 0.945 | 0.801 | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
| 79. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
2.696 | - | - | 0.863 | 0.872 | 0.961 | - | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
| 80. | MligTC455_33277 | 1450 | 30.2 | Mlig455_031182 | Neo: - Age: - Region-specific R2: 3.361 Region-enriched R2: 2.732/0.00000 |
TRO | 2.694 | - | - | 0.791 | 0.935 | 0.968 | - | Mlig455_031182 {REF} {Length: 1600} {Human: ENSG00000067445, TRO, trophinin, [Score=52.8, Expect=3e-08]} {Smed: dd_Smed_v6_1015_0_1, dd_Smed_v6_1015_0_1, [RH, Score=43.9, Expect=3e-06]} {RNA1509_34972} {RNA1310_37320, RNA1509_34972} {RNA1509_34972, RNA815_25574} |
| 81. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.693 | - | - | 0.906 | 0.807 | 0.980 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 82. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
2.693 | - | - | 0.774 | 0.939 | 0.980 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
| 83. | MligTC455_49296 | 69 | 1.44 | Mlig455_034352, Mlig455_034414 | Neo: - Age: - |
2.685 | - | - | 0.985 | 0.798 | 0.902 | - | Mlig455_034352 {REF} {Length: 912} {TRANSSPLICED} Mlig455_034414 {REF} {Length: 919} {TRANSSPLICED} |
|
| 84. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
2.68 | - | - | 0.917 | 0.798 | 0.965 | - | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
| 85. | MligTC455_42457 | 63 | 1.31 | Mlig455_020182 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.680 Region-enriched R4: 3.390/0.03030 |
2.679 | 0.961 | - | 0.730 | - | 0.988 | - | Mlig455_020182 {REF} {Length: 1595} {TRANSSPLICED} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=57.0, Expect=2e-10]} {RNA1509_59965} {RNA1310_27831} {RNA815_27307} | |
| 86. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
2.672 | - | - | 0.920 | 0.792 | 0.960 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
| 87. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
2.671 | - | - | 0.775 | 0.967 | 0.929 | - | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
| 88. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 2.671 | - | - | 0.821 | 0.874 | 0.976 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
| 89. | MligTC455_10953 | 148 | 3.08 | Mlig455_060864, Mlig455_063528 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.497/0.01237 |
KCNH7 | 2.67 | - | - | 0.842 | 0.874 | 0.954 | - | Mlig455_060864 {REF} {Length: 7144} {Pfam: Ion transport protein [PF00520.33, score=117.5]; Cyclic nucleotide-binding domain [PF00027.31, score=52.7]; Ion channel [PF07885.18, score=45.4]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=777, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=760, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=751, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=776, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=761, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=751, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=712, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=798, Expect=0.0]} {RNA1509_40124} {RNA1310_4074} {RNA815_8044} Mlig455_063528 {REF} {Length: 734} {NoTransDecoderORF} |
| 90. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
2.668 | - | - | 0.769 | 0.929 | 0.970 | - | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
| 91. | MligTC455_20154 | 22 | 0.45 | Mlig455_002425 | Neo: - Age: - |
OTOP2 | 2.667 | - | - | 0.980 | 0.898 | 0.789 | - | Mlig455_002425 {REF} {Length: 2659} {Pfam: Otopetrin [PF03189.15, score=233.1]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=55.1, Expect=3e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=62.4, Expect=1e-09]} {Dmel: FBgn0259150, CG42265, [Score=197, Expect=2e-52]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=117, Expect=6e-27]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=296, Expect=3e-91]} {RNA1310_52344} {RNA815_48323} |
| 92. | MligTC455_24523 | 144 | 2.99 | Mlig455_010636, Mlig455_010724 | Neo: - Age: - Region-enriched R2: 9.355/0.00000 |
RGS6 | 2.667 | - | - | 0.913 | 0.964 | 0.790 | - | Mlig455_010636 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=116.4]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=301, Expect=3e-95]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=299, Expect=2e-94]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=290, Expect=6e-91]} {Dmel: FBgn0259927, CG42450, [RH, Score=327, Expect=2e-98]} {Celegans: WBGene00001145, eat-16, [Score=217, Expect=1e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=384, Expect=1e-127]} {RNA1509_59108} {RNA1310_13711, RNA1509_59108} {RNA1509_59108, RNA815_9935} Mlig455_010724 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=113.1]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=299, Expect=2e-94]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=297, Expect=2e-93]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=287, Expect=4e-90]} {Dmel: FBgn0259927, CG42450, [RH, Score=324, Expect=1e-97]} {Celegans: WBGene00001145, eat-16, [Score=214, Expect=8e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=382, Expect=8e-127]} {RNA1509_59108} {RNA1310_13711} {RNA815_9935} |
| 93. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 2.664 | - | - | 0.801 | 0.902 | 0.961 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
| 94. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
2.662 | - | - | 0.769 | 0.967 | 0.926 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
| 95. | MligTC455_52199 | 1032 | 21.49 | Mlig455_031255, Mlig455_031301 | Neo: - Age: Down-Down-Up |
2.66 | 0.953 | - | - | - | 0.883 | 0.824 | Mlig455_031255 {REF} {Length: 1896} {Pfam: Innexin [PF00876.20, score=210.3]} {Celegans: WBGene00002127, inx-5, Innexin-5, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_734_0_1, dd_Smed_v6_734_0_1, [Score=139, Expect=1e-36]} {RNA1509_2324} {RNA1310_13247} {RNA815_6165.1} Mlig455_031301 {REF} {Length: 2187} {Pfam: Innexin [PF00876.20, score=210.3]} {Celegans: WBGene00002127, inx-5, Innexin-5, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_734_0_1, dd_Smed_v6_734_0_1, [Score=139, Expect=2e-36]} {RNA1509_2324} {RNA1310_13247} {RNA815_6165.1} |
|
| 96. | MligTC455_41988 | 81 | 1.68 | Mlig455_049279, Mlig455_050624 | Neo: - Age: - |
2.658 | - | - | 0.951 | 0.802 | 0.905 | - | Mlig455_049279 {REF} {Length: 6361} {Pfam: Innexin [PF00876.20, score=408.1]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=1e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=341, Expect=5e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=483, Expect=3e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_25566} Mlig455_050624 {REF} {Length: 2845} {Pfam: Innexin [PF00876.20, score=408.0]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=2e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=342, Expect=3e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=484, Expect=1e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_1848.2} |
|
| 97. | MligTC455_20476 | 29 | 0.61 | Mlig455_009224 | Neo: - Age: - |
2.657 | - | - | 0.968 | 0.933 | 0.756 | - | Mlig455_009224 {REF} {Length: 1688} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
| 98. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
2.655 | - | - | 0.736 | 0.933 | 0.986 | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
| 99. | MligTC455_16609 | 80 | 1.68 | Mlig455_020102 | Neo: - Age: - |
WSCD2 | 2.653 | 0.964 | - | 0.889 | 0.800 | - | - | Mlig455_020102 {REF} {Length: 980} {Pfam: WSC domain [PF01822.21, score=56.5]; PAN domain [PF00024.28, score=25.6]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=58.5, Expect=2e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.5, Expect=1e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=9e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
| 100. | MligTC455_21389 | 173 | 3.6 | Mlig455_012718 | Neo: - Age: - |
SLC9B2 | 2.653 | 0.979 | - | 0.769 | - | 0.905 | - | Mlig455_012718 {REF} {Length: 3209} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=114.5]; Sodium/glutamate symporter [PF03616.16, score=18.4]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=320, Expect=3e-100]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=303, Expect=5e-94]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=257, Expect=4e-75]} {Celegans: WBGene00009618, F41E7.2, [Score=136, Expect=9e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=359, Expect=2e-116]} {RNA1509_19376} {RNA1310_19487} {RNA815_52764} |
There are 872 more genes with r >= 0.95